uncategorised
Joint Royal College of Ophthalmologists and BOPSS ‘Multidisciplinary Oculoplastics- Bringing you the Best’ Seminar Thursday 24 June 2021 We have lined up an exciting panel of speakers and the format will consist of short update talks and Q & A sessions interspersed. We are hoping that there will be a face to face component so this will be something to look forward to in the Summer! More info will be added here
In view of government advice and lockdown into late Spring 2021, the Executive has made a decision to postpone the Oxford meeting until July 2023. The 2022 BOPSS meeting will take place in Manchester as originally planned. The Executive is pleased to announce that BOPSS will be jointly organising with the College an oculoplastics seminar chaired by Vickie Lee on 24th June 2021. BOPSS will be organising a webinar in November 2021 with more details to follow shortly. [...]
In the year which long promised the hope of eradication of preventable eye disease across the world, 2020 has been overshadowed by the effects of the respiratory virus SARS-CoV-2. The pandemic has profoundly affected us all, our ability to serve our patients, to teach the next generation of doctors, and, for BOPSS, the ability to run our annual meetings. Although the UK’s national vaccination program is underway, the recent emergence of a more virulent strain of virus, dubbed B117, means [...]
BOPSS warmly welcomes you to its first virtual symposium. This will take place on Thursday 15th October 2020 between 6pm and 8pm. As ever, BOPSS is being innovative and we are hosting “Six of the Best” where 6 members representing the breadth of our membership talk on six subjects to share six pearls from their experiences The meeting will take place on zoom and is FREE. Access to the meeting will be given nearer the time following registration. More info here [...]
BOPSS has been working closely with TEAMeD to implement TEAMeD-5. The aim is to increase awareness among clinicians and patients of the importance of prevention, diagnosis and prompt referral of patients with Thyroid Eye Disease. A directory has been created to give information about thyroid eye services in different regions of the UK. This information is intended to assist healthcare professionals making referrals for their patients with this condition. BOPSS does not accept any responsibility or liability for the accuracy [...]
It is with great sadness and a heavy heart that we must let you know of the passing of our colleague Tony Tyers. As many of you will know, Tony bore a progressive illness over the past few years with characteristic strength, resilience, and commitment both to his family and his work. He was a great teacher, a towering authority in ophthalmology, and a true friend to us all. Amongst his many contributions, Tony will be remembered for his [...]
The AoMRC has requested that BOPSS remind members that we may be the primary physician for patients who are at high risk of increased morbidity and mortality from COVID-19 (1). These patients are being asked to consider complete self-isolation – or shielding – for their own safety. A template letter (2) which can be sent to such patients and the information sent out by NHSE (3) is available. Additional information can be found on the AoMRC website https://www.aomrc.org.uk/covid-19-clinical/ (1) AoMRC letter to clinicians (2) [...]
Given the escalating situation we have now decided to postpone the Oxford Meeting. An autumn virtual meeting will be run instead. More info on this event will be made shortly. Updated 20/1/2021
Through BOPSS, Rebecca Ford and her team completed a UK survey on the provision of eyelid surgery for patients with thyroid eye disease (TED). The conclusions were presented at the 2019 BOPSS meeting. Provision for this surgery varies depending on the individual CCGs. Before approval is obtained for eyelid surgery, however, most patients will have had to apply for individual funding requirements (IFR), secured prior approval (PA) or met the criteria for a planned procedure with a threshold (PPPwT). These approvals [...]
Retrobulbar Hyaluronidase to reverse CRAO following injection of facial fillers. The consensus is both in review and animal studies1-8 that, as yet, there is not conclusive evidence to support this treatment. Only a limited number of case reports and theoretical proposals have been recorded in support of the technique9,10. Thus, it is our advice that ophthalmology units do not need to be equipped to provide an emergency retrobulbar hyaluronidase service. Best practice dictates that all practitioners should be aware of [...]
